CONDUIT TFT80932TRecalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10705034557953), received between Feb 10, 2026 and Feb 10, 2026 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryFeb 10, 2026Adverse Event Without Identified Device or Use Problem

  IT WAS REPORTED THAT DURING A TLIF(L4-5-S1) PROCEDURE FOR LCS WHEN THE SURGEON WAS PLACING A TRIAL (32MM X 9MM HIGH) INTO THE L5/S INTERVERTEBRAL DISC SPACE, IT WAS INSERTED DEEPER THAN INTENDED, POTENTIALLY DAMAGING A BLOOD VESSEL (NAME OF VESSEL UNCONFIRMED) VENTRAL TO THE VERTEBRAL BODY. AFTER HAMMERING THE TRIAL, FLUOROSCOPY CONFIRMED THAT THE TRIAL WAS POSITIONED VENTRAL TO THE VERTEBRAL BODY, REVEALING IMPROPER PLACEMENT OF THE TRIAL. THE TRIAL WAS IMMEDIATELY REMOVED WITH A SLAP HAMMER. ANATOMICALLY, A LARGE BLOOD VESSEL IS LOCATED VENTRAL TO THE VERTEBRAL BODY, SO THE ASSISTANT URGED FOR AN URGENT BLOOD PRESSURE CHECK. A DROP IN BLOOD PRESSURE WAS NOTED, TEMPORARILY HALTING THE SURGERY. DETERMINING THAT VASCULAR INJURY HAD OCCURRED, THE ASSISTANT AND ANESTHESIOLOGIST, PRIMARILY, ADMINISTERED MEDICATION, ADMINISTERED HEMOSTATIC AGENTS, ORDERED BLOOD TRANSFUSIONS, AND ARRANGED FOR TRANSPORT TO THE EMERGENCY CENTER (AMBULANCE). THE ASSISTANT DETERMINED THAT IT WOULD BE BEST NOT TO CONTINUE THE SURGERY, AND THE INTERVERTEBRAL DISC SPACE WAS TREATED WITH HEMOSTATIC AGENTS AND GAUZE PACKING, AND THE WOUND WAS CLOSED. THE PATIENT WAS PLACED IN A SUPINE POSITION AND AWAITED EMERGEN

  Patient problems: Perforation of Vessels

  MAUDE report 24309236 ↗